Massachusetts Financial Services’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $241M | Buy |
3,560,621
+1,626,169
| +84% | +$108M | 0.08% | 235 |
|
|
2026
Q1 | $122M | Buy |
1,934,452
+1,141,025
| +144% | +$79.5M | 0.04% | 330 |
|
|
2025
Q4 | $52.7M | Sell |
793,427
-4,815,048
| -86% | -$311M | 0.02% | 465 |
|
|
2025
Q3 | $377M | Sell |
5,608,475
-997,212
| -15% | -$78.9M | 0.12% | 180 |
|
|
2025
Q2 | $577M | Buy |
6,605,687
+3,410,858
| +107% | +$267M | 0.18% | 136 |
|
|
2025
Q1 | $218M | Buy |
3,194,829
+2,015,971
| +171% | +$165M | 0.07% | 253 |
|
|
2024
Q4 | $91.7M | Sell |
1,178,858
-252,106
| -18% | -$18.7M | 0.03% | 396 |
|
|
2024
Q3 | $95.9M | Sell |
1,430,964
-1,008,069
| -41% | -$82.8M | 0.03% | 393 |
|
|
2024
Q2 | $277M | Buy |
2,439,033
+353,019
| +17% | +$44.6M | 0.09% | 212 |
|
|
2024
Q1 | $289M | Buy |
2,086,014
+218,229
| +12% | +$27.4M | 0.09% | 208 |
|
|
2023
Q4 | $232M | Buy |
+1,867,785
| New | +$191M | 0.07% | 229 |
|
|
2021
Q1 | – | Sell |
-66,252
| Closed | -$6.12M | – | 926 |
|
|
2020
Q4 | $6.12M | Sell |
66,252
-1,385,600
| -95% | -$124M | ﹤0.01% | 669 |
|
|
2020
Q3 | $150M | Sell |
1,451,852
-113,800
| -7% | -$11.9M | 0.05% | 260 |
|
|
2020
Q2 | $159M | Buy |
1,565,652
+324,896
| +26% | +$29.1M | 0.06% | 242 |
|
|
2020
Q1 | $83.5M | Buy |
1,240,756
+316,316
| +34% | +$19.7M | 0.04% | 296 |
|
|
2019
Q4 | $50.6M | Buy |
924,440
+122,444
| +15% | +$5.81M | 0.02% | 411 |
|
|
2019
Q3 | $29.9M | Buy |
801,996
+66,272
| +9% | +$2.57M | 0.01% | 476 |
|
|
2019
Q2 | $27.6M | Sell |
735,724
-373,320
| -34% | -$11.7M | 0.01% | 486 |
|
|
2019
Q1 | $33M | Buy |
1,109,044
+163,844
| +17% | +$5.76M | 0.01% | 449 |
|
|
2018
Q4 | $28.3M | Buy |
945,200
+158,964
| +20% | +$5.04M | 0.01% | 458 |
|
|
2018
Q3 | $28.1M | Sell |
786,236
-72,264
| -8% | -$2.24M | 0.01% | 480 |
|
|
2018
Q2 | $20.4M | Sell |
858,500
-755,644
| -47% | -$16M | 0.01% | 514 |
|
|
2018
Q1 | $29.9M | Sell |
1,614,144
-636,308
| -28% | -$9.41M | 0.01% | 451 |
|
|
2017
Q4 | $32.3M | Buy |
2,250,452
+60,300
| +3% | +$784K | 0.01% | 457 |
|
|
2017
Q3 | $26.8M | Buy |
2,190,152
+540,088
| +33% | +$9.55M | 0.01% | 467 |
|
|
2017
Q2 | $30.2M | Buy |
1,650,064
+229,132
| +16% | +$4.23M | 0.01% | 465 |
|
|
2017
Q1 | $30.1M | Buy |
1,420,932
+113,744
| +9% | +$2.22M | 0.01% | 453 |
|
|
2016
Q4 | $19.5M | Buy |
1,307,188
+11,788
| +0.9% | +$209K | 0.01% | 507 |
|
|
2016
Q3 | $28.4M | Sell |
1,295,400
-276,428
| -18% | -$6.15M | 0.01% | 459 |
|
|
2016
Q2 | $31.2M | Buy |
1,571,828
+52,220
| +3% | +$889K | 0.02% | 430 |
|
|
2016
Q1 | $25.8M | Buy |
1,519,608
+159,080
| +12% | +$2.66M | 0.01% | 461 |
|
|
2015
Q4 | $27.9M | Buy |
1,360,528
+292,784
| +27% | +$6.09M | 0.01% | 441 |
|
|
2015
Q3 | $22.9M | Sell |
1,067,744
-244,824
| -19% | -$5.46M | 0.01% | 461 |
|
|
2015
Q2 | $26.2M | Sell |
1,312,568
-714,380
| -35% | -$12.5M | 0.01% | 467 |
|
|
2015
Q1 | $31.6M | Sell |
2,026,948
-179,380
| -8% | -$2.71M | 0.02% | 430 |
|
|
2014
Q4 | $30.4M | Sell |
2,206,328
-1,311,616
| -37% | -$16.1M | 0.02% | 420 |
|
|
2014
Q3 | $35.2M | Sell |
3,517,944
-135,160
| -4% | -$1.38M | 0.02% | 410 |
|
|
2014
Q2 | $36.2M | Buy |
3,653,104
+3,382,224
| +1,249% | +$30M | 0.02% | 415 |
|
|
2014
Q1 | $2.8M | Sell |
270,880
-87,120
| -24% | -$900K | ﹤0.01% | 688 |
|
|
2013
Q4 | $3.17M | Sell |
358,000
-3,245,720
| -90% | -$25.7M | ﹤0.01% | 650 |
|
|
2013
Q3 | $25.4M | Buy |
3,603,720
+3,263,880
| +960% | +$20.7M | 0.02% | 433 |
|
|
2013
Q2 | $1.91M | Buy |
+339,840
| New | +$1.63M | ﹤0.01% | 663 |
|
Other funds holding DXCM
Massachusetts Financial Services's DXCM Position: Q2 2026 in Review
Massachusetts Financial Services increased its DexCom (DXCM) stake by 84% in Q2 2026, buying an estimated $108M and bringing the position to 3,560,621 shares worth $241M. The position accounts for 0.08% of the portfolio, ranked #235.
Massachusetts Financial Services first reported a position in DXCM in Q2 2013 and has held it in 42 quarters since. The position peaked at $577M in Q2 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Massachusetts Financial Services held 3,560,621 shares of DexCom worth $241M as of Q2 2026.
- Massachusetts Financial Services bought 1,626,169 DexCom shares in Q2 2026, an estimated $108M.
- DexCom made up 0.08% of Massachusetts Financial Services's portfolio in Q2 2026, its #235 holding.
- Massachusetts Financial Services first reported a position in DexCom in Q2 2013 and has held it in 42 quarters since.
- Massachusetts Financial Services's DexCom position peaked at $577M in Q2 2025.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.